Site icon B-empire magazine

CVS Plans to Separate Its Pharmacies and Health Services

Photo : Flying Freddy/Wikimedia Commons — CC BY-SA 3.0.

CVS Health wants to unwind part of the empire it spent years assembling. The US group announced on November 4 that it intends to become two independent, publicly traded companies: a healthcare-solutions business bringing together Aetna, CVS Caremark and care operations, and a separate company focused on pharmacies and community health services. The separation is targeted for the first half of 2028. It has not happened yet: closing conditions, approvals and regulatory filings remain outstanding.

Two businesses, two operating models

The first business, which would temporarily keep the CVS Health name, would include insurer Aetna, pharmacy-benefit manager CVS Caremark, CVS Specialty, Oak Street Health and Signify Health. The second, called CVS Pharmacy, would include about 9,000 pharmacies, mail pharmacy, MinuteClinic, including virtual care, and the Health100 technology business. The proposal separates coverage, benefit management and care delivery on one side from a pharmacy and community-services network on the other.

The two companies would have separate leaders. David Joyner, CVS Health’s current chair and chief executive, would lead the healthcare-solutions company; Prem Shah, currently a group president, would become CEO of CVS Pharmacy. CVS says additional leadership and board appointments will be announced later. Existing shareholders are expected to receive shares in both businesses if the transaction proceeds. The company is seeking a separation intended to be tax-free to CVS and its US shareholders, but that treatment also remains subject to the required confirmations.

The bet: make each business easier to understand

For years, CVS has combined activities that intersect in a patient’s journey: insurance, prescription-benefit management, pharmacies, clinics and care services. In theory, an integrated model can coordinate services, direct patients toward lower-cost care and connect coverage decisions with available treatment. But it also brings together businesses with different economics, regulations and investor expectations. The proposed split suggests management believes a more specialized structure could focus teams and capital more clearly.

CVS presents the transaction as a way to give each company its own strategy, financial structure and investment priorities. The company says both should retain investment-grade credit ratings, solid cash generation and flexibility in capital allocation. These are expectations stated by the company, not outcomes already achieved. As the plan develops, investors will need to assess separation costs, debt allocation, shared expenses and any savings that may come from operating independently.

The split will not remove complexity by itself

Breaking up a vertically integrated company does not automatically make healthcare simpler for patients. The two businesses will still need to coordinate where their operations meet: network contracts, prescription reimbursement, data, care pathways, specialty services and relationships with employers or public programmes. The separation must determine who owns information systems, how data moves and which commercial agreements connect the former divisions. Poorly designed interfaces could add friction instead of removing it.

CVS says customers and patients will continue to receive medicines, benefits and services without interruption during the process. In the short term, the announcement therefore does not mean pharmacies are closing or coverage is changing immediately. Over time, the test will be whether the healthcare-solutions company can keep linking insurance, specialty pharmacy and value-based care, while CVS Pharmacy broadens partnerships with insurers, benefit managers and manufacturers. The result will depend on contracts as much as on the organization chart.

A timetable of almost two years

CVS is targeting the first half of 2028, subject to customary conditions, including final board approval, effectiveness of a Form 10 registration statement with the Securities and Exchange Commission, and confirmation of the intended tax treatment. Until then, the group says it will continue operating as it does today and pursue its financial targets. The timetable allows time to establish legal structures, allocate assets and obligations, prepare independent systems and inform employees, customers and partners.

The period will also test governance. The companies will need to explain how they divide shared costs, debt commitments, technology investment and responsibilities to insured members and patients. CVS employs nearly 30,000 pharmacists and reports about 87 million members in its pharmacy-benefit-management business, as well as roughly 37 million people served by its insurance products and related services, based on figures as of September 30, 2026. Those numbers illustrate the operational scale of a separation, without predicting how the new companies will perform.

Value will be judged after the announcement

Breakups can make businesses easier to compare and allow teams to focus on different markets. They can also create transition costs, sacrifice economies of scale and move problems from one division to another instead of solving them. CVS says a simpler structure will improve experience and coordination; those benefits will need to show up in spending, access to care, service quality and financial results. The proposed separation is neither proof that integration has failed everywhere nor a guarantee that two independent companies will do better.

The more important signal is that CVS now sees a reason to distinguish its physical community network from its combined insurance-pharmacy-care business. For the company built around Aetna and Caremark, the question will be whether it can preserve links that create genuine value without retaining costly complexity. For CVS Pharmacy, the challenge will be turning thousands of points of contact into viable health services, not just retail locations. Between the announcement and early 2028, details on debt, contracts and approvals will show whether this is a strategic redesign or largely a financial repackaging.

Sources

Exit mobile version